VHT
Vanguard Health Care ETF
Vanguard Health Care ETF seeks to track the performance of the MSCI US Investable Market Health Care Index.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 17.6 B
ASSETS UNDER MGMT
9 bp
EXPENSES
Fund Basics
| Inception date | Jan 26, 2004 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Delayed |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| ELI LILLY & CO | 13.4 % |
| JOHNSON & JOHNSON | 8.8 % |
| ABBVIE INC | 6.4 % |
| UNITEDHEALTH GROUP INC | 5.5 % |
| MERCK & CO. INC. | 4.7 % |
| THERMO FISHER SCIENTIFIC INC | 3.1 % |
| AMGEN INC | 3.0 % |
| ABBOTT LABORATORIES | 2.7 % |
| GILEAD SCIENCES INC | 2.3 % |
| PFIZER INC | 2.1 % |
Constituent Breakdown
| Number of holdings | 428 |
| Herfindahl-Hirschman Index | 445 |
| Wgt avg mkt cap (mns) | $324,264 |
| Large cap (>$10bn) | 91.1% |
| Mid cap ($2-10bn) | 6.6% |
| Small cap (<$2bn) | 1.8% |
| Developed mkts. | 99.5% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 96.8 % |
 |
IRELAND | 2.3 % |
Historical Performance
Standardized Performance (as of 07/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 5.9% | 26.2% | 5.3% | 7.2% | 3.5% | 8.3% | 9.0% | 8.4% |
| Dividend Yield | 0.8% | 2.2% | 1.7% | 1.7% | 1.5% | 1.6% | 1.7% | 1.5% |
| Total Returns | 6.7% | 28.4% | 7.1% | 8.9% | 5.1% | 9.9% | 10.7% | 9.9% | Ann. Volatility | 16.2% | 15.2% | 15.9% | 14.4% | 15.3% | 17.0% | 17.4% | 16.9% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.37 | 9% |
| MSCI EAFE | 0.39 | 16% |
| MSCI Emg Mkts | 0.07 | 1% |
Liquidity Measures
| Avg. volume (000) | 248 |
| ADV traded (mns) | $76 |
| Turnover | 0.4% |
| Avg. Bid/Ask (% of price) | 0.03% |
Technical Indicators
| 30d moving avg. (EMA) | $300.32 |
| Relative strength (RSI) | 57 |
| MACD/Signal | 4.02/4.38 |
| Bollinger Bands (Upper/Lower) | $312.45/$296.93 |
| Short interest (% of AUM) | 0.3% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. VHT |
Expenses vs. VHT |
ALTAR Score™ vs. VHT |
|---|---|---|---|---|
| FHLC | Fidelity MSCI Health Care Index ETF | 95.8% | -1 bp | +0.2% |
| IYH | iShares U.S. Healthcare ETF | 86.9% | +31 bp | +0.7% |
| XLV | Health Care Select Sector SPDR | 85.0% | -1 bp | +1.5% |
| IXJ | iShares Global Healthcare ETF | 72.0% | +33 bp | +1.4% |
| HRTS | Tema Heart & Health ETF | 54.2% | +66 bp | -2.1% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 47.5% | +31 bp | +1.2% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 45.1% | +51 bp | +1.6% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 41.0% | +66 bp | -3.9% |
| MEDX | Horizon Kinetics Medical ETF | 40.4% | +76 bp | -3.8% |
| PINK | Simplify Health Care ETF | 40.3% | +41 bp | -3.9% |
Risk and Returns: VHT vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 8/3/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
5.3%
ALTAR SCORE™
49th
PERCENTILE
NEUTRAL
ETFRC RATING
There are 1,402 funds in the US Equity category with an average
ALTAR Score™ of 5.3% and a standard deviation
of 2.0%. VHT's ALTAR Score™ is approximately 0.0 standard
deviations above the category average. This places VHT in the 49th percentile
among funds in the category.
Sell-Side Consensus
$333.89
PRICE TARGET
+9.5%
UPSIDE